Search the Archive

In Depth (Weight Loss: Safety) #722344

NBC Evening News for Sunday, Feb 23, 2003
View other clips in this broadcast →

Material supplied by VTNA may be used for educational analysis or research only. Any editing, reproduction, publication, rebroadcast, public showing or public display may be prohibited by copyright laws. For any such use, please visit NBC NEWS Archives XPRESS.

(Studio: John Seigenthaler) Report introduced.

(Chicago: Ralph Stafford?) The ongoing controversy over the weight loss drug ephedra that resurfaced with the spring training death of Baltimore Orioles baseball player Steve Bechler examined. [At health club, GUY - comments.] [Brother Mike BECHLER†- talks about his brother's case.] [Broward County medical examiner Dr. Joshua PERPER†- raises the ephedra link to Bechler's death.] [Retired Army Col. Dr. John KARK‡, Ephedra Education Council lawyer Wes SIEGNER††- offer differing opinions on the safety of ephedra use.]

Seigenthaler, John;
Stafford, Ralph

Note to sponsor members: The Vanderbilt Television News Archive video player requires a modern operating system and browser to work properly. If you are experiencing playback problems, check the minimum requirements and adjust your setup accordingly. After adjustments, if you continue to experience problems, please contact us.

Welcome! Above is the abstract of the item that you're interested in viewing from the Vanderbilt Television News Archive's collection. You have three options if you'd like to view this item:

  • You may request a loan of this video by registering on our website and placing an order.
  • You may visit the Television News Archive on the Vanderbilt campus to view on-site from the Archive's collection.
  • If you are associated with a college or university, you may ask your library if they would like to become a sponsor, which would give students and faculty at your institution the ability to view items from our collection.

If you believe that you are associated with a sponsoring college or university and have received this message in error, please let us know.